Advanced search
1 file | 128.16 KB

Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane

(2007) EYE. 21(11). p.1433-1434
Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 128.16 KB

Citation

Please use this url to cite or link to this publication:

Chicago
RUYS, J, Jean Delaey, Y VANDERHAEGHEN, and Elisabeth Van Aken. 2007. “Intravitreal Bevacizumab (Avastin) for the Treatment of Bilateral Acquired Juxtafoveal Retinal Telangiectasis Associated with Choroidal Neovascular Membrane.” EYE 21 (11): 1433–1434.
APA
RUYS, J., Delaey, J., VANDERHAEGHEN, Y., & Van Aken, E. (2007). Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane. EYE, 21(11), 1433–1434.
Vancouver
1.
RUYS J, Delaey J, VANDERHAEGHEN Y, Van Aken E. Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane. EYE. NATURE PUBLISHING GROUP; 2007;21(11):1433–4.
MLA
RUYS, J, Jean Delaey, Y VANDERHAEGHEN, et al. “Intravitreal Bevacizumab (Avastin) for the Treatment of Bilateral Acquired Juxtafoveal Retinal Telangiectasis Associated with Choroidal Neovascular Membrane.” EYE 21.11 (2007): 1433–1434. Print.
@article{392603,
  author       = {RUYS, J and Delaey, Jean and VANDERHAEGHEN, Y and Van Aken, Elisabeth},
  issn         = {0950-222X},
  journal      = {EYE},
  language     = {eng},
  number       = {11},
  pages        = {1433--1434},
  publisher    = {NATURE PUBLISHING GROUP},
  title        = {Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane},
  volume       = {21},
  year         = {2007},
}

Web of Science
Times cited: